Login / Signup

Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor.

Patrick-Pascal StrunzMarc SchmalzingAnke HeidemeierLeo RascheHermann EinseleKlaus Martin Kortüm
Published in: Leukemia & lymphoma (2019)
Keyphrases
  • stem cell transplantation
  • diffuse large b cell lymphoma
  • epstein barr virus
  • high dose
  • multiple myeloma